Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity.

Saved in:
Bibliographic Details
Title: Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity.
Authors: Du Y; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America., Hertoghs N; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America., Duffy FJ; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America., Carnes J; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America., McDermott SM; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America., Neal ML; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America., Schwedhelm KV; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Aitchison JD; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America., Stuart KD; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2022 Feb 02; Vol. 18 (2), pp. e1010282. Date of Electronic Publication: 2022 Feb 02 (Print Publication: 2022).
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1553-7374
DOI:10.1371/journal.ppat.1010282